Introduction
============

First described by Wiethe in 1882, optic disc pits are small, gray-white, oval depressions found at the optic nerve head.[@b1-opth-7-167] Optic pits are a relatively rare clinical entity, with an estimated incidence of one in 11,000 people. Men and women are affected equally, and optic pits usually appear sporadically.[@b2-opth-7-167]--[@b4-opth-7-167] They are usually found on the inferotemporal border of the optic nerve head, and 25%--75% of patients have macular involvement.[@b4-opth-7-167],[@b8-opth-7-167] Visual loss in patients with optic pits may be associated with retinoschisis and/or serous retinal detachment involving the macula.

Unanswered questions surrounding this condition include the origin of the macular fluid and the variable clinical features seen in individual patients. Although many reports have been published on the subject, the majority of publications are limited to case series and brief reports because of the rarity of this entity.[@b5-opth-7-167]--[@b7-opth-7-167] Lincoff et al proposed that fluid from optic pits forms a schisis-like cavity in the retina initially, then progresses to a retinal hole in the outer layer and allows fluid to track subretinally.[@b9-opth-7-167] However, subsequent optical coherence tomography (OCT) studies have shown serous detachment associated with optic disc maculopathy without schisis-like cavities.[@b10-opth-7-167]--[@b12-opth-7-167]

The purpose of the current study is to report a consecutive series of patients at a university referral center over a 10-year period, including presenting features, clinical course, and spectral-domain OCT documenting the status of the macula.

Materials and methods
=====================

The University of Miami institutional review board approved this retrospective study, which was conducted in accordance with the principles of the Declaration of Helsinki. The inclusion criteria were a diagnosis of optic disc pit and presentation between the years 2001 and 2011. All data were obtained via a retrospective chart review and entered into a standard computerized database for subsequent analysis. Patients were divided into two main groups, ie, patients with optic pit maculopathy who were observed without surgery and patients with optic pit maculopathy who received surgical intervention. The data collected included demographics (age and gender), visual acuity, surgical information, OCT findings, clinical characteristics of the optic pit, and complications. Patients without maculopathy, those who did not undergo OCT imaging, and those who had only one visit and no follow-up were excluded.

Results
=======

In the current series of 18 eyes, the mean age of patients at diagnosis was 27.9 years. There were nine male and nine female patients. Four of the patients presented with bilateral optic nerve pits. Nine of 18 pits were inferotemporal, seven were temporal, and two were inferior. Median length of follow-up was 19.5 months ([Table 1](#t1-opth-7-167){ref-type="table"}). The visual acuity of the patients who had optic pit maculopathy and were observed without surgery is shown in [Table 2](#t2-opth-7-167){ref-type="table"}. Six of a total of eight patients had ≥20/200 vision on presentation, which remained unchanged at the last follow-up. The average length of follow-up was 95.5 (range 3--310) months.

The visual acuity of 10 patients with optic pit maculopathy who had either surgery or laser is shown in [Table 3](#t3-opth-7-167){ref-type="table"}. Of these 10 patients, two received only laser; six patients had ≥20/200 visual acuity on presentation and eight had ≥20/200 visual acuity at the last follow-up. The average length of follow-up was 71.6 (range 6--310) months. In the surgical group, persistent subretinal or intraretinal fluid occurred in four of seven patients. One patient had severe retinal pigment epithelium atrophy limiting postoperative visual acuity, and another patient developed a macular hole after surgery ([Figure 6](#f6-opth-7-167){ref-type="fig"}).

OCT findings for all the patients with optic pit maculopathy are described in [Table 4](#t4-opth-7-167){ref-type="table"}. The location of the fluid was most often in the outer nuclear layer or in the subretinal space, although a significant portion of patients also had fluid in the inner nuclear layer. Twelve of 18 patients had a schisis-like cavity in the macula on OCT. [Figures 1](#f1-opth-7-167){ref-type="fig"}--[6](#f6-opth-7-167){ref-type="fig"} shows the sequential OCT images of representative patients with varying clinical courses.

Discussion
==========

Observational studies have shown that long-standing macular retinal detachment from optic pits is generally associated with poor visual acuity.[@b13-opth-7-167] Poor visual acuity (\<20/200) on presentation is another predictor of poor visual outcome in these patients. In the observed patients, all with ≥20/200 vision on presentation maintained that degree of vision over a reasonable follow-up duration. The patients who presented with poor vision (\<20/200) and were observed did not have visual improvement during follow-up. This is likely because of loss of photoreceptors which, in many cases, can be seen on SD-OCT. [Figures 1](#f1-opth-7-167){ref-type="fig"} and [3](#f3-opth-7-167){ref-type="fig"} both show significant macular schisis cavities which were able to maintain 20/25 vision for greater than 10 years. This is likely because the schisis-like cavity had not affected the foveal center, and although they maintained excellent Snellen acuity, a visual deficit is seen in the visual field in [Figure 3](#f3-opth-7-167){ref-type="fig"}. However, in both of these cases, the schisis-like cavity remained stable over a long period with no significant changes.

SD-OCT findings in the observed group revealed many cases with schisis-like cavities, and also a number of cases with only subretinal fluid. SD-OCT studies of optic pits have shown that most cases of optic pit maculopathy have schisis-like cavities on SD-OCT.[@b14-opth-7-167] The fluid is most often observed in the outer nuclear layer, as described in prior OCT studies of optic pit maculopathy. However, macular fluid can be found in any of a number of layers. It is unclear if location of the fluid plays a role in how stable the vision will be if observed. The most common postoperative finding on OCT is persistent intraretinal or subretinal fluid, which may have limited the final visual acuity.

In the current series, many of the patients with optic pit maculopathy were observed. Surgical intervention had mixed benefit in the treatment of this rare condition. Variability in type of intervention may have contributed to the different visual and anatomical outcomes, and is certainly a limitation of this study. SD-OCT enables improved understanding of the anatomical changes and visual impact of optic pit maculopathy.
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![Observed patient with progression of schisis-like cavity over 6 year period.\
(Patient one, [Table 2](#t2-opth-7-167){ref-type="table"})](opth-7-167f1){#f1-opth-7-167}

![Observed patient with variable subretinal fluid over 1 year.\
(Patient 3, [Table 2](#t2-opth-7-167){ref-type="table"})](opth-7-167f2){#f2-opth-7-167}

![Observed patient with schisis cavity, and visual field deficit.\
(Patient 2, [Table 2](#t2-opth-7-167){ref-type="table"})](opth-7-167f3){#f3-opth-7-167}

![Good visual recovery after surgery with persistent intraretinal fluid.\
(Patient 17, [Table 3](#t3-opth-7-167){ref-type="table"})](opth-7-167f4){#f4-opth-7-167}

![Good visual recovery with good anatomic outcome.](opth-7-167f5){#f5-opth-7-167}

![Development of macular hole after surgery.\
(Patient 18, [Table 3](#t3-opth-7-167){ref-type="table"})](opth-7-167f6){#f6-opth-7-167}

###### 

Demographics and clinical characteristics

  Optic Pits 18 patients, 18 eyes   
  --------------------------------- -----------------------
  Mean on presentation (years)      27.9 (range 3--69)
  Gender                            
   M = male                         M = 9
   F = female                       F = 9
  Laterality                        
   RE = Right eye                   RE = 7
   LE = Left eye                    LE = 11
  Bilateral (patients)              4/18
  Location of pit                   Temporal = 7/18
                                    Inferotemporal = 9/18
                                    Inferior = 2/18
  Median follow up (months)         19.5

###### 

Optic pit maculopathy observed without surgery

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient   Age   Gender   Eye   Location         VA (initial)   VA (last)   Schisis-like cavity   Location of fluid on OCT   Length of follow up (months)   Comment
  --------- ----- -------- ----- ---------------- -------------- ----------- --------------------- -------------------------- ------------------------------ -------------------------
  1         46    F        LE    Inferotemporal   20/20          20/20       Yes                   SRF, ONL, INL\             192                            
                                                                                                   GCL, SILM                                                 

  2         59    F        LE    Inferotemporal   20/25          20/25       Yes                   ONL                        204                            

  3         7     F        LE    Inferotemporal   20/50          20/80       No                    SRF                        11                             

  4         20    M        LE    Inferotemporal   20/60          20/70       No                    SRF                        3                              

  5         39    M        LE    Temporal         20/200         20/200      Yes                   SRF, ONL                   24                             

  6         23    M        LE    Inferotemporal   20/200         20/200      Yes                   SRF, ONL                   4                              

  7         65    M        LE    Inferior         3/200          1/200       No                    None                       310                            Significant RPE atrophy

  8         24    M        RE    Inferior         1/200          HM          Yes                   SRF, ONL, INL              16                             Chronic cystic RD
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** SRF, subretinal fluid; ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer; SILM, sub-internal limiting membrane; VA, visual acuity; LE, left eye; RE, right eye; RPE, retinal pigment epithelium; RD, retinal detachment.

###### 

Optic pit maculopathy receiving intervention

  Patient   Age   Gender   Eye   Location         VA (initial)   VA (last)   Type of intervention                Outcome                 Schisis-like cavity   Location of fluid on OCT   Length of follow up (months)
  --------- ----- -------- ----- ---------------- -------------- ----------- ----------------------------------- ----------------------- --------------------- -------------------------- ------------------------------
  9         50    F        RE    Temporal         20/30          20/70       Barrier laser                       Persistent fluid        No                    INL, SILM                  122
  10        51    F        LE    Inferotemporal   20/60          20/50       PPV/MP/AFX/laser                    Persistent fluid        Yes                   SRF, ONL                   6
  11        34    F        LE    Temporal         20/70          20/200      Peripapillary barrier laser         Persistent fluid        Yes                   ONL, INL, SILM             112
  12        30    F        RE    Temporal         20/100         20/60       PPV/ILM peel/ subretinal drainage   No macular fluid        No                    SRF                        19
  13        65    M        RE    Inferotemporal   20/100         20/400      PPV/AFX/laser                       Persistent fluid                              SRF                        310
  14        77    M        RE    Inferotemporal   20/125         20/200      PPV/AFX/laser/ drainage             No macular fluid        Yes                   SRF, ONL                   9
  15        37    F        RE    Inferotemporal   20/400         20/200      PPV/MP/AFX/laser                    Persistent fluid        Yes                   SRF, ONL, INL              20
  16        13    M        LE    Temporal         20/400         20/200      PPV/MP/AFX/laser                    Flat with RPE atrophy   Yes                   SRF, ONL                   98
  17        17    M        RE    Temporal         3/200          20/60       PPV/MP/AFX/laser                    Persistent fluid        Yes                   SRF, ONL, INL              6
  18        38    F        LE    Temporal         20/400         20/200      PPV/MP/AFX                          Macular hole            Yes                   SRF, ONL, INL, GCL         9

**Abbreviations:** SRF, subretinal fluid; ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer; SILM, sub-internal limiting membrane; PPV, pars plana vitrectomy; MP, membrane peel; AFX, air fluid exchange; RPE, retinal pigmented epithelium; VA, visual acuity.

###### 

Location of fluid for all optic pits with maculopathy on optical coherence tomography

  n = 17              SRF     ONL     INL    GCL    SILM   Schisis-like cavity
  ------------------- ------- ------- ------ ------ ------ ---------------------
  Location of fluid   14/18   12/18   8/18   3/18   4/18   12/18

**Abbreviations:** SRF, subretinal fluid; ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer; SILM, sub-internal limiting membrane.
